Worsening of psychosis with clozapine and selective serotonin reuptake inhibitor combination: Two case reports

被引：35
作者：
Chong, SA
Tan, CH
Lee, HS
机构：
[1] WOODBRIDGE HOSP, SINGAPORE, SINGAPORE
[2] NATL UNIV SINGAPORE, DEPT PHARMACOL, SINGAPORE 117548, SINGAPORE
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1997年 / 17卷 / 01期
关键词：
D O I：
10.1097/00004714-199702000-00024
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：68 / 69
页数：2
相关论文
共 11 条
[1]  
ALLEN L, 1994, AM J PSYCHIAT, V151, P1096
[2]   CYTOCHROME P4502D6 GENOTYPE DOES NOT DETERMINE RESPONSE TO CLOZAPINE [J].
ARRANZ, MJ ;
DAWSON, E ;
SHAIKH, S ;
SHAM, P ;
SHARMA, T ;
AITCHISON, K ;
CROCQ, MA ;
GILL, M ;
KERWIN, R ;
COLLIER, DA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (04) :417-420
[3]   FLUVOXAMINE IS A POTENT INHIBITOR OF CYTOCHROME-P4501A2 [J].
BROSEN, K ;
SKJELBO, E ;
RASMUSSEN, BB ;
POULSEN, HE ;
LOFT, S .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (06) :1211-1214
[4]  
CASSADY SL, 1992, AM J PSYCHIAT, V149, P1274
[5]  
DEVANE CL, 1994, J CLIN PSYCHIAT, V55, P38
[6]   FLUVOXAMINE INHIBITION AND CARBAMAZEPINE INDUCTION OF THE METABOLISM OF CLOZAPINE - EVIDENCE FROM A THERAPEUTIC DRUG-MONITORING SERVICE [J].
JERLING, M ;
LINDSTROM, L ;
BONDESSON, U ;
BERTILSSON, L .
THERAPEUTIC DRUG MONITORING, 1994, 16 (04) :368-374
[7]  
MACVICAR K, 1997, AM J PSYCHIAT, V134, P809
[8]  
MILLER DD, 1994, J CLIN PSYCHIAT, V55, P117
[9]  
PIRMOHAMED M, 1995, J PHARMACOL EXP THER, V272, P984
[10]  
SILVER H, 1995, AM J PSYCHIAT, V152, P1098
12